journal article·2021-09-29Open access

Core Hydrophobicity of Supramolecular Nanoparticles Induces NLRP3 Inflammasome Activation

Dipika Nandi, Manisha Shivrayan, Jingjing Gao, Jithu Krishna, Ritam Das, Bin Liu, S. Thayumanavan, Ashish Kulkarni

ACS Applied Materials & Interfaces· Volume 13· Issue 38

Abstract

Designer nanomaterials capable of delivering immunomodulators to specific immune cells have been extensively studied. However, emerging evidence suggests that several of these nanomaterials can nonspecifically activate NLRP3 inflammasomes, an intracellular multiprotein complex controlling various immune cell functions, leading to undesirable effects. To understand what nanoparticle attributes activate inflammasomes, we designed a multiparametric polymer supramolecular nanoparticle system to modulate various surface and core nanoparticle-associated molecular patterns (NAMPs), one at a time. We also investigated several underlying signaling pathways, including lysosomal rupture-cathepsin B maturation and calcium flux-mitochondrial ROS production, to gain mechanistic insights into NAMPs-mediated inflammasome activation. Here, we report that out of the four NAMPs tested, core hydrophobicity strongly activates and positively correlates with the NLRP3 assembly compared to surface charge, core rigidity, and surface hydrophobicity. Moreover, we demonstrate different signaling inclinations and kinetics followed by differential core hydrophobicity patterns with the most hydrophobic ones exhibiting both lysosomal rupture and calcium influx early on. Altogether, this study will help design the next generation of polymeric nanomaterials for specific regulation of inflammasome activation, aiding efficient immunotherapy and vaccine delivery.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Inflammasome and immune disorders · Heme Oxygenase-1 and Carbon Monoxide · Streptococcal Infections and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical Engineering, University of Massachusetts, Amherst, Massachusetts 01003, United States

Department of Veterinary and Animal Sciences, University of Massachusetts, Amherst, Massachusetts 01003, United States

Department of Chemistry, University of Massachusetts, Amherst, Massachusetts 01003, United States

Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, 02139, United States

Department of Biomedical Engineering, University of Massachusetts, Amherst, Massachusetts, 01003, United States

Center for Bioactive Delivery, Institute for Applied Life Sciences, University of Massachusetts, Amherst, Massachusetts 01003, United States

Funding

Melanoma Research Alliance · American Cancer Society · Cancer Research Institute · National Institute of General Medical Sciences

References (79)

Show source-provided references
1. 10.1016/S1097-2765(02)00599-310.1016/S1097-2765(02)00599-3 ↗
2. 10.1038/nrmicro207010.1038/nrmicro2070 ↗
3. 10.1038/s41419-019-1413-810.1038/s41419-019-1413-8 ↗
4. 10.3390/ijms2013332810.3390/ijms20133328 ↗
5. 10.1038/nrd.2018.9710.1038/nrd.2018.97 ↗
6. 10.1016/j.tibs.2016.09.00210.1016/j.tibs.2016.09.002 ↗
7. 10.4049/jimmunol.190076410.4049/jimmunol.1900764 ↗
8. 10.1016/j.cell.2016.03.04610.1016/j.cell.2016.03.046 ↗
9. 10.1038/ni.223710.1038/ni.2237 ↗
10. 10.1002/smll.20150227310.1002/smll.201502273 ↗
11. 10.1016/j.smim.2017.08.01310.1016/j.smim.2017.08.013 ↗
12. 10.1039/C9BM01643K10.1039/C9BM01643K ↗
13. 10.2217/nnm-2017-020810.2217/nnm-2017-0208 ↗
14. 10.1007/s11882-012-0302-310.1007/s11882-012-0302-3 ↗
15. 10.1515/aiht-2015-66-258210.1515/aiht-2015-66-2582 ↗
16. 10.1002/jcp.2747510.1002/jcp.27475 ↗
17. 10.1039/C8NR00554K10.1039/C8NR00554K ↗
18. 10.1038/cddis.2014.57610.1038/cddis.2014.576 ↗
19. 10.1038/ni.163110.1038/ni.1631 ↗
20. 10.1177/175342591773833110.1177/1753425917738331 ↗
21. 10.1016/j.tiv.2019.10466310.1016/j.tiv.2019.104663 ↗
22. 10.1039/D0NR05067A10.1039/D0NR05067A ↗
23. 10.1002/mabi.20170027310.1002/mabi.201700273 ↗
24. 10.1074/jbc.M111.23851910.1074/jbc.M111.238519 ↗
25. 10.1016/j.biomaterials.2012.06.01610.1016/j.biomaterials.2012.06.016 ↗
26. 10.1186/1743-8977-10-310.1186/1743-8977-10-3 ↗
27. 10.1038/ncomms260810.1038/ncomms2608 ↗
28. 10.1155/2015/14372010.1155/2015/143720 ↗
29. 10.1002/smll.20120196210.1002/smll.201201962 ↗
30. Sharma B. · 2018 · 1682 · 13510.1007/978-1-4939-7352-1_12 ↗
31. 10.1002/smll.20130048110.1002/smll.201300481 ↗
32. 10.1093/toxsci/kfw01110.1093/toxsci/kfw011 ↗
33. 10.1021/acsami.8b1747410.1021/acsami.8b17474 ↗
34. 10.1016/j.smim.2017.09.00310.1016/j.smim.2017.09.003 ↗
35. 10.1021/nn200595c10.1021/nn200595c ↗
36. 10.1021/nn203596e10.1021/nn203596e ↗
37. 10.4049/jimmunol.120049210.4049/jimmunol.1200492 ↗
38. 10.1039/C8BM01643G10.1039/C8BM01643G ↗
39. 10.1186/s12989-016-0150-810.1186/s12989-016-0150-8 ↗
40. 10.1021/acscentsci.8b0021810.1021/acscentsci.8b00218 ↗
41. 10.1021/acsami.8b0471810.1021/acsami.8b04718 ↗
42. 10.1002/smll.20190164210.1002/smll.201901642 ↗
43. 10.1016/j.tiv.2018.12.00910.1016/j.tiv.2018.12.009 ↗
44. 10.1039/C4BM00140K10.1039/C4BM00140K ↗
45. 10.1021/ja210890510.1021/ja2108905 ↗
46. 10.1016/j.smim.2017.09.01110.1016/j.smim.2017.09.011 ↗
47. 10.1002/anie.20171006810.1002/anie.201710068 ↗
48. 10.1021/acs.nanolett.0c0446810.1021/acs.nanolett.0c04468 ↗
49. 10.1039/C8NR09381D10.1039/C8NR09381D ↗
50. 10.1002/adma.20140478810.1002/adma.201404788 ↗
51. 10.1016/j.vaccine.2009.03.03410.1016/j.vaccine.2009.03.034 ↗
52. 10.1073/pnas.080489710610.1073/pnas.0804897106 ↗
53. 10.1016/j.mib.2009.12.00110.1016/j.mib.2009.12.001 ↗
54. 10.1002/anie.20200274810.1002/anie.202002748 ↗
55. 10.4161/hv.2958910.4161/hv.29589 ↗
56. 10.1039/D1SM00864A10.1039/D1SM00864A ↗
57. 10.1002/anie.20200827210.1002/anie.202008272 ↗
58. 10.1021/acs.chemmater.0c0110710.1021/acs.chemmater.0c01107 ↗
59. De Nardo D. · 2018 · 1784 · 3510.1007/978-1-4939-7837-3_4 ↗
60. 10.3390/ijms2112429410.3390/ijms21124294 ↗
61. 10.1016/j.yrtph.2020.10461810.1016/j.yrtph.2020.104618 ↗
62. 10.1073/pnas.100815510710.1073/pnas.1008155107 ↗
63. 10.3390/nano711035510.3390/nano7110355 ↗
64. 10.3390/nano711035510.3390/nano7110355 ↗
65. 10.1021/ar300064710.1021/ar3000647 ↗
66. 10.1038/ni.291310.1038/ni.2913 ↗
67. 10.1038/sj.cdd.440219410.1038/sj.cdd.4402194 ↗
68. 10.1084/jem.2015179010.1084/jem.20151790 ↗
69. 10.1016/j.celrep.2014.07.01210.1016/j.celrep.2014.07.012 ↗
70. 10.1080/08958378.2016.125766410.1080/08958378.2016.1257664 ↗
71. 10.1016/j.taap.2017.01.01210.1016/j.taap.2017.01.012 ↗
72. 10.1038/cddis.2015.27710.1038/cddis.2015.277 ↗
73. 10.1016/j.nantod.2020.10106110.1016/j.nantod.2020.101061 ↗
74. 10.1002/cti2.110910.1002/cti2.1109 ↗
75. 10.1038/s41422-018-0093-810.1038/s41422-018-0093-8 ↗
76. 10.1021/acsmacrolett.5b0061510.1021/acsmacrolett.5b00615 ↗
77. 10.1016/j.biomaterials.2011.11.01910.1016/j.biomaterials.2011.11.019 ↗
78. 10.1016/S0168-3659(99)00114-510.1016/S0168-3659(99)00114-5 ↗
79. 10.3390/biomimetics503003210.3390/biomimetics5030032 ↗